Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma E Tiacci, E Ladewig, G Schiavoni, A Penson, E Fortini, V Pettirossi, ... Blood, The Journal of the American Society of Hematology 131 (22), 2454-2465, 2018 | 218 | 2018 |
GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling O Bereshchenko, M Coppo, S Bruscoli, M Biagioli, M Cimino, ... Cell reports 7 (2), 464-475, 2014 | 137 | 2014 |
Long glucocorticoid-induced leucine zipper (L-GILZ) protein interacts with ras protein pathway and contributes to spermatogenesis control S Bruscoli, E Velardi, M Di Sante, O Bereshchenko, A Venanzi, M Coppo, ... Journal of Biological Chemistry 287 (2), 1242-1251, 2012 | 89 | 2012 |
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML E Tiacci, A Venanzi, S Ascani, A Marra, V Cardinali, G Martino, V Codoni, ... New England Journal of Medicine 379 (10), 981-984, 2018 | 64 | 2018 |
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin L Brunetti, V Di Battista, A Venanzi, G Schiavoni, MP Martelli, S Ascani, ... Leukemia 31 (5), 1238-1240, 2017 | 51 | 2017 |
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML MP Martelli, R Rossi, A Venanzi, M Meggendorfer, VM Perriello, G Martino, ... Blood, The Journal of the American Society of Hematology 138 (25), 2696-2701, 2021 | 39 | 2021 |
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial E Tiacci, L De Carolis, E Simonetti, M Merluzzi, A Bennati, VM Perriello, ... Leukemia 35 (11), 3314-3318, 2021 | 34 | 2021 |
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML I Gionfriddo, L Brunetti, F Mezzasoma, F Milano, V Cardinali, R Ranieri, ... Leukemia 35 (9), 2552-2562, 2021 | 33 | 2021 |
Overlapping features of therapy-related and de novo NPM1-mutated AML J Othman, M Meggendorfer, E Tiacci, C Thiede, R Schlenk, R Dillon, ... Blood 141 (15), 1846-1857, 2023 | 30 | 2023 |
Dissecting clonal hematopoiesis in tissues of patients with classic Hodgkin lymphoma A Venanzi, A Marra, G Schiavoni, SG Milner, R Limongello, A Santi, ... Blood cancer discovery 2 (3), 216-225, 2021 | 26 | 2021 |
New recurrently mutated genes in classical hodgkin lymphoma revealed by whole-exome sequencing of microdissected tumor cells E Tiacci, A Penson, G Schiavoni, E Ladewig, E Fortini, Y Wang, ... Blood 128 (22), 1088, 2016 | 15 | 2016 |
Recombinant long-glucocorticoid-induced leucine zipper (L-GILZ) protein restores the control of proliferation in gilz KO spermatogonia A Venanzi, M Di Sante, S Bruscoli, M Biagioli, D Sorcini, M Cimino, ... European Journal of Pharmaceutical Sciences 63, 22-28, 2014 | 15 | 2014 |
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing … L Falini, A Venanzi, V Tini, A Innocente, S Ballanti, S Saldi, S Sivolella, ... Haematologica 108 (1), 290, 2023 | 7 | 2023 |
A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 in Acute Myeloid Leukemia (AML) A Venanzi, R Rossi, G Martino, O Annibali, G Avvisati, MG Mameli, ... Genes 12 (9), 1426, 2021 | 4 | 2021 |
One disease, two faces: clonally-related AML and MPDCP with skin involvement G Martino, G Cimino, M Caridi, G Perta, V Cardinali, S Sciabolacci, ... Annals of Hematology 102 (10), 2969-2971, 2023 | 1 | 2023 |
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor V Pettirossi, A Venanzi, A Spanhol-Rosseto, G Schiavoni, A Santi, ... Leukemia 37 (2), 473-477, 2023 | 1 | 2023 |
Abstract LB044: Tracking clonal hematopoiesis in patients with classical Hodgkin lymphoma A Marra, A Venanzi, G Schiavoni, SG Milner, R Limongello, A Santi, ... Cancer Research 81 (13_Supplement), LB044-LB044, 2021 | 1 | 2021 |
Novel mutations and translocations involving Nucleophosmin (NPM1) gene in acute myeloid leukemia (AML) and leading to aberrant cytoplasmic NPM1 MP Martelli, R Rossi, A Venanzi, M Meggendorfer, V Perriello, O Spinelli, ... HAEMATOLOGICA 103, S18-S19, 2018 | 1 | 2018 |
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement G Martino, G Cimino, M Caridi, G Perta, V Cardinali, S Sciabolacci, ... Annals of hematology 103 (4), 1421, 2024 | | 2024 |
An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine A Marra, A Santi, A Pucciarini, A Venanzi, L De Carolis, F Zaja, S Ascani, ... American journal of hematology 99 (3), 497-501, 2024 | | 2024 |